Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr1.04 DKK
Change Today -0.02 / -1.89%
Volume 659.5K
VELO On Other Exchanges
As of 4:07 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christie M. Ballantyne M.D.

Member of Cardiovascular Scientific Advisory Board, Veloxis Pharmaceuticals A/S
AgeTotal Calculated CompensationThis person is connected to 40 board members in 3 different organizations across 6 different industries.

See Board Relationships


Dr. Christie M. Ballantyne, M.D., serves as Professor, Section of Atherosclerosis, Department of Medicine, Baylor College of Medicine. Dr. Ballantyne serves as Director, Center for Cardiovascular Disease Prevention, Methodist DeBakey Center. He serves as Chief, Section of Atherosclerosis and Vascular Medicine; Director, The Maria and Alando J. Ballantyne, M.D., Atherosclerosis Clinical Research Laboratory; and Co-Director, Lipid Metabolism and Atherosclerosis Clinic, ...

Read Full Background

Corporate Headquarters*

Bøge Allé 5, 2th
Hørsholm, Capital Region of Denmark 2970


Phone: 45 70 33 33 00
Fax: 45 36 13 03 19

Board Members Memberships*

There is no Board Members Memberships data available.


Baylor College of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VELO:DC kr1.04 DKK -0.02


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VELOXIS PHARMACEUTICALS A/S, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at